44 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Cacna2d2du/Cacna2d2du involves: C3H * DBA/2J	abnormal miniature endplate potential	J:121463
	abnormal motor neuron morphology	J:121463
	abnormal neuromuscular synapse morphology	J:121463
	decreased body weight	J:121463
	decreased neurotransmitter release	J:121463
Cacna2d2du/Cacna2d2du involves: DBA/2J	abnormal gait	J:116
	decreased body size	J:116
	decreased survivor rate	J:116
	reduced female fertility	J:116
	reduced male fertility	J:116
Cacna2d2du/Cacna2d2du TKDU	abnormal CNS glial cell morphology	J:152373
	abnormal dorsal spinal root morphology	J:152373
	abnormal gait	J:152373
	abnormal glial cell physiology	J:152373
	abnormal hindbrain development	J:152373
	abnormal hindbrain morphology	J:152373
	abnormal medulla oblongata morphology	J:152373
	abnormal myelination	J:152373
	abnormal neuron morphology	J:152373
	abnormal Purkinje cell morphology	J:152373
	abnormal spinal cord morphology	J:152373
	abnormal spinal nerve morphology	J:152373
	abnormal stationary movement	J:152373
	abnormal ventral spinal root morphology	J:152373
	abnormal vertebral column morphology	J:152373
	ataxia	J:152373
	axonal dystrophy	J:152373
	decreased body size	J:152373
	decreased neuron number	J:152373
	decreased pons size	J:152373
	decreased Purkinje cell number	J:152373
	decreased spinal cord size	J:152373
	hindlimb paralysis	J:152373
	induced hyperactivity	J:152373
	premature death	J:152373
	Purkinje cell degeneration	J:152373
	seizures	J:152373
	short vertebral body	J:152373
	skeletal muscle hypoplasia	J:152373
	small cerebellum	J:152373
Cacna2d2du/Cacna2d2du TKDU/DnJ	abnormal enzyme/coenzyme activity	J:5175
	abnormal myelination	J:5263
	abnormal spinal cord white matter morphology	J:43719
	decreased brain weight	J:5263
	normal endocrine/exocrine gland phenotype	J:5263
	induced hyperactivity	J:5263
	normal nervous system phenotype	J:43719, J:70845
	postnatal growth retardation	J:5263
	seizures	J:5263